Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Phase I Study of the JAK2 V617F Inhibitor
34-12-16(23)21(31)35-18)15-8-7-13-5-4-6-17(29)24(13
Automated synthesis of 4-[(18)F]fluoroanisole
than it was in cells activated by PHA
CAS Number: 78950-78-4
N-Benzylacetamidine (hydrobromide) Size:Contact [email protected] for quotation Phase I Study of theIC50: 0. 20 M: inhibits inducible nitric oxide synthases (iNOS). IC50: 350 M: blocks endothelial nitric oxide synthases (eNOS). N Benzylacetamidine is a potent and selective inhibitor of iNOS compared to eNOS. NOS is essential to the formation of nitric oxide (NO) via the NADPH and O2 dependent oxidation of L arginine, which plays a role in regulating many pathological and physiological processes, including smooth muscle relaxation and